Press Releases
May 23, 2023
Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
May 16, 2023
Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting
May 03, 2023
Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
Apr 26, 2023
Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023
Apr 20, 2023
Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry
Mar 29, 2023
Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days
Mar 22, 2023
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Mar 02, 2023
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
Feb 09, 2023
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference